Jul 1 |
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
|
May 28 |
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024
|
May 14 |
InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript
|
May 14 |
InspireMD GAAP EPS of -$0.21, revenue of $1.51M
|
May 14 |
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 14 |
InspireMD Insider Ups Holding By 13% During Year
|
May 13 |
InspireMD Q1 2024 Earnings Preview
|
May 7 |
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th
|
Apr 3 |
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 31 |
InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year
|